July 9 (Reuters) - RLS Global AB RLSC.ST :
* RLS CLINICAL TRIAL - CHLORASOLV01 - IS COMPLETED AND THE
RESULT
IS TO BE ANALYZED
* DATABASE FOR CHLORASOLV01 IS CLOSED AND RLS HAS RECEIVED
FIRST
STATISTICAL REPORT AND RESULTS
* CHLORASOLV01 IS A PILOT STUDY IN WHICH PATIENT WITH
CHRONIC
ULCERS ON LOWER LEG OR FOOT IS TREATED WITH CHLORASOLV FOR FIVE
WEEKS
* STUDY ENDPOINTS INCLUDE FOR EXAMPLE REDUCTION OF
DEVITALIZED
TISSUE (NECROTIC TISSUE) AND REDUCTION OF WOUND SIZE.
Source text for Eikon: ID:nWkrc3lKNh
Further company coverage: RLSC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))